Immunosuppressive Agents: all 5,940 studies that test it
Page 53 of 60. Open to participants first (674), then studies with results posted, then the rest; newest registration first within each.
- Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia, or Myeloproliferative DisordersCompletedNCT00293410Phase 1
- Multicenter Randomized Prospective Trial Comparing Methotrexate Alone or in Combination With Adalimumab in Early ArthritisStatus unknownNCT00291915Phase 4
- Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic CancerCompletedNCT00290641Not applicable
- Renal Function Optimization With Mycophenolate Mofetil (MMF) Immunosuppressor Regimes (ALHAMBRA)Status unknownNCT00290069Phase 4
- High-Dose Methotrexate in Treating Young Patients With Residual EpendymomaStatus unknownNCT00287924Phase 2
- Phase II Randomized, Double-Blind, Placebo-Controlled Study of BMS-188667 (CTLA4Ig) in Patients With Psoriasis VulgarisCompletedNCT00287547Phase 2
- Anti-Thymocyte Globulin, Cyclosporine, and RAD in Islet TransplantationCompletedNCT00286624Phase 1/2
- Safety and Efficacy of Basiliximab in Calcineurin Inhibitor Intolerant Long-term Kidney Transplant Recipients Treated With Mycophenolic Acid and SteroidsCompletedNCT00284947Phase 4
- Use of Daclizumab for the Prevention of Allograft Rejection in Pediatric Heart Transplant PatientsTerminatedNCT00284531Phase 1/2
- Use of Thalidomide in Patients With ArachnoiditisCompletedNCT00284505Phase 2
- Association of L-asparaginase-Methotrexate-Dexamethasone for Nasal and Nasal-type Natural Killer (NK)-T-cell LymphomaCompletedNCT00283985Phase 2
- Study Evaluating Sirolimus in the Treatment of Kidney TransplantCompletedNCT00282217Phase 4
- Fludarabine and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Lymphocytic Leukemia or Waldenstrom's MacroglobulinemiaCompletedNCT00281983Phase 1/2
- Fludarabine, Cyclophosphamide, and Rituximab in Treating Patients With Prolymphocytic LeukemiaTerminatedNCT00281931Phase 2
- Leflunomide in Rheumatoid ArthritisCompletedNCT00280644Phase 4
- Vaccination Study of Abatacept (BMS-188667) for Normal Healthy VolunteersCompletedNCT00279734Phase 1
- Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's LymphomaCompletedNCT00278421Phase 3
- Combination Chemotherapy and Radiation Therapy With or Without Methotrexate in Treating Young Patients With Newly Diagnosed GliomasStatus unknownNCT00278278Phase 3
- A Study to Assess the Pharmacokinetics, Immunogenicity and Safety of Escalating Doses of BMS-188667 Given as a Single Intravenous Infusion to Patients With Psoriasis VulgarisCompletedNCT00277225Phase 1
- Comparability DE vs CD-CHO1CompletedNCT00277199Phase 1
- Fludarabine With or Without Cyclophosphamide in Treating Patients With Advanced Chronic Lymphocytic LeukemiaCompletedNCT00276848Phase 3
- Combination Chemotherapy and Thalidomide in Treating Younger Patients Undergoing Surgery For Newly Diagnosed Liver CancerStatus unknownNCT00276705Phase 2
- Bevacizumab, Everolimus, and Erlotinib in Treating Patients With Advanced Solid TumorsCompletedNCT00276575Phase 1
- TNF Alpha in Refractory AsthmaCompletedNCT00276029Not applicable
- The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant RecipientsCompletedNCT00275535Phase 4
- The Comparison of Three Different Immunosuppressant Regimens in Kidney Transplant Recipients.CompletedNCT00275522Phase 4
- Rituximab, Fludarabine, and Cyclophosphamide or Observation Alone in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic LeukemiaCompletedNCT00275054Phase 3
- Cyclophosphamide and Total Body Irradiation in Treating Patients Who Are Undergoing an Autologous Peripheral Stem Cell Transplant For Chronic Lymphocytic LeukemiaCompletedNCT00275015Phase 2
- Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative DisorderCompletedNCT00274820Phase 2
- Aerosol Cyclosporine for Prevention of Lung RejectionCompletedNCT00268515Phase 2
- Study Comparing Two Sirolimus Regimens vs. Tacrolimus and Mycophenolate Mofetil Regimen in Kidney Transplant RecipientsCompletedNCT00266123Phase 4
- Metabolic Pattern of Cyclosporine A and Acute Renal FailureCompletedNCT00264355Phase 4
- Higher Frequency Zoledronic Acid in the Treatment of Multiple MyelomaCompletedNCT00263484Phase 2
- Study Comparing Two Immunosuppressive Regimens in De Novo Renal Allograft RecipientsCompletedNCT00261820Phase 4
- Cladribine, Cytarabine, and Imatinib Mesylate in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Blastic Phase Chronic Myelogenous LeukemiaCompletedNCT00258271Phase 1
- Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell LeukemiaCompletedNCT00258245Phase 1
- Study Evaluating Cyclosporine Dose Reduction and Cyclosporine Elimination in Chinese Kidney TransplantsCompletedNCT00257387Phase 1/2
- Everolimus in Treating Patients WIth Recurrent or Metastatic Breast CancerCompletedNCT00255788Phase 2
- Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic CancerCompletedNCT00255710Phase 1
- Study Evaluating Two Different Sirolimus-based Immunosuppressive Regimens in Elderly Kidney Transplant RecipientsCompletedNCT00254709Phase 4
- RAD001 Plus Docetaxel in Patients With Metastatic Breast CancerTerminatedNCT00253318Phase 1
- Study Evaluating the Combination of Etanercept and Methotrexate in Rheumatoid Arthritis SubjectsCompletedNCT00252668Phase 4
- Use of Sirolimus vs. Tacrolimus For African-American Renal Transplant RecipientsStatus unknownNCT00252655Phase 4
- A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS TumorsCompletedNCT00251797Phase 1
- Trial of Thalidomide, a- Interferon +/- Octreotide in Patients With Unresectable Hepatocellular CarcinomaCompletedNCT00250796Phase 2
- Enbrel Liquid Immunogenicity ProtocolCompletedNCT00249041Phase 3
- Study Comparing Cyclosporin Dose Reduction With Cyclosporin Elimination in Kidney Transplant Recipients Taking SirolimusCompletedNCT00248313Phase 3
- Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Embryonal RhabdomyosarcomaStatus unknownNCT00245141Phase 2
- Vincristine, Dactinomycin, and Cyclophosphamide in Treating Patients With Embryonal RhabdomyosarcomaStatus unknownNCT00245089Phase 2
- Open Label, Single Arm, Phase II Study Using R-COMP in Elderly Patients With Aggressive NHL.Status unknownNCT00244127Phase 2
- Methotrexate in Ankylosing Spondylitis (MTX in AS)Status unknownNCT00243750Phase 2
- Fludarabine and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Metastatic Kidney Cancer That Cannot Be Removed By SurgeryTerminatedNCT00243009Phase 2
- Rituximab, Cyclophosphamide, and G-CSF Followed By Combination Chemotherapy in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant Followed By Rituximab and GM-CSF for Refractory Diffuse Large B-Cell LymphomaCompletedNCT00242996Phase 2
- Efficacy of Cyclophosphamide Versus Methylprednisolone in Patients With Secondary Progressive Multiple SclerosisCompletedNCT00241254Phase 3
- Rapamycin vs Methotrexate in Diffuse SScCompletedNCT00241189Phase 1/2
- Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant RecipientsCompletedNCT00239902Phase 2
- Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant RecipientsCompletedNCT00239876Phase 3
- Efficacy and Safety of FTY720 Versus Mycophenolate Mofetil (MMF, Roche Brand) in de Novo Adult Renal Transplant RecipientsCompletedNCT00239863Phase 3
- Long Term Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant RecipientsCompletedNCT00239811Phase 3
- Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant RecipientsCompletedNCT00239798Phase 2
- Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant RecipientsCompletedNCT00239785Phase 3
- Efficacy and Safety of Basiliximab in Hepatitis C Virus Positive Patients Undergoing Liver TransplantationCompletedNCT00238901Phase 3
- PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic MelanomaCompletedNCT00238329Phase 2
- Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain TumorsTerminatedNCT00238173Phase 1
- Evaluation of Topical Antipsoriatics in the Psoriasis Plaque TestCompletedNCT00236171Not applicable
- Adalimumab Administered in Korean Rheumatoid Arthritis Subjects Treated With MethotrexateCompletedNCT00235859Phase 3
- Safety and Efficacy of Adalimumab to Methotrexate and Placebo in Subjects With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT00235820Phase 3
- Single Dose Thymoglobulin for Induction in Adult Renal Allograft RecipientsTerminatedNCT00235781Not applicable
- Rapamycin in Combination With Low-dose Aracytin in Elderly Acute Myeloid Leukemia PatientsCompletedNCT00235560Phase 2
- Adalimumab in Combination With Methotrexate vs Methotrexate Alone in Early Rheumatoid ArthritisCompletedNCT00234845Phase 3
- Open-Label Steroid Reduction Study of Adalimumab With Methotrexate in Patients With Active Rheumatoid ArthritisTerminatedNCT00233558Phase 4
- Melphalan, Prednisone and Thalidomide Versus Melphalan and Prednisone in Elderly Myeloma PatientsCompletedNCT00232934Phase 3
- Pimecrolimus Cream 1% in Adult Patients With Perioral DermatitisCompletedNCT00232115Phase 3
- Verification Study of Ciclosporin for Atopic DermatitisCompletedNCT00232076Phase 3
- Long-term Study of Ciclosporin for Atopic DermatitisCompletedNCT00232063Phase 3
- Extension Study to Assess Safety and Efficacy of Pimecrolimus in Adult Patients With Atopic DermatitisCompletedNCT00232011Phase 3
- Extension Study of Pimecrolimus Cream in Pediatric Patients With Atopic DermatitisCompletedNCT00231998Phase 3
- MMF, Daclizumab and Corticosteroids as Mainstay Immunosuppression in Renal Transplant PatientsCompletedNCT00231764Phase 4
- Pilot-Study of Thalidomide in Amyotrophic Lateral Sclerosis (ALS)TerminatedNCT00231140Phase 2
- PST/Laser v. Laser Alone for CSMEStatus unknownNCT00229918Phase 2
- IMM 0212: Busulfan With Fludarabine and Antithymocyte Globulin as Preparative Therapy for Hematopoietic Stem Cell Transplant for the Treatment of Severe Congenital T-Cell ImmunodeficiencyCompletedNCT00228852Phase 1/2
- Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu VaccineCompletedNCT00228358Phase 1
- Long Term Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With RelapsesCompletedNCT00228163Phase 2
- Arsenic Trioxide, Thalidomide, Dexamethasone, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple MyelomaTerminatedNCT00227682Phase 2
- A Trial of Thalidomide and Capecitabine in Metastatic Renal Cell CarcinomaCompletedNCT00226980Phase 2
- Pimecrolimus Cream 1% in Patients (18 Years of Age and Over) With Mild to Moderate Chronic Hand DermatitisCompletedNCT00226707Phase 3
- To Determine the Role of Adding Campath-1H or ATG Given In-vivo in Addition to Fludarabine and Low Dose Busulfex on Outcome in Patients Treated With Reduced Intensity ConditioningWithdrawnNCT00226512Phase 3
- A Study Comparing the Acceptability of Pentasa® Sachets Versus Pentasa® Tablets in Children With Crohn´s DiseaseCompletedNCT00225810Phase 4
- Phase III Trial of Oral Thalidomide in Advanced Hepatocellular Carcinoma With Poor Liver ReserveTerminatedNCT00225290Phase 3
- Combination Chemotherapy +/- Radiation in High Risk Hodgkin's DiseaseTerminatedNCT00225173Phase 2
- Phase II Trial of Enbrel in Patients With Primary Systemic AmyloidosisCompletedNCT00224393Phase 2
- Cutaneous Lupus Erythematosus and ElidelWithdrawnNCT00222183Not applicable
- IFM 99-02 Thalidomide in MyelomaCompletedNCT00222053Phase 3
- A Safety Study of Rituximab Plus MTX Injected Into the Cerebrospinal Fluid in the Treatment of Brain LymphomaCompletedNCT00221325Phase 1
- A Study to Confirm the Efficacy and Safety of Fludarabine Phosphate Administered in Untreated Chronic Lymphocytic Leukemia Patients With Anemia and/or ThrombocytopeniaCompletedNCT00220311Phase 4
- Thalidomide to Patients With Previously Untreated Multiple MyelomaCompletedNCT00218855Phase 3
- Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic SyndromesCompletedNCT00217386Phase 2
- Vinblastine and Methotrexate in Children With Pulmonary Vein StenosisCompletedNCT00215046Phase 2
- Renal Function Evaluation After Reduction of Cyclosporine A Dose in Renal Transplant PatientsCompletedNCT00213590Phase 3
- Phase II Study of Combined Modality Treatment in Primary Testicular Non-Hodgkin's LymphomaCompletedNCT00210379Phase 2